Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 665

1.

Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.

Neville JA, Prescott LE, Bhattacherjee V, Adams N, Pike I, Rodgers B, El-Zayadi A, Hamid S, Dusheiko GM, Saeed AA, Haydon GH, Simmonds P.

J Clin Microbiol. 1997 Dec;35(12):3062-70.

3.
4.
5.

Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.

Prescott LE, Simmonds P, Lai CL, Chan NK, Pike I, Yap PL, Lin CK.

J Med Virol. 1996 Oct;50(2):168-75.

PMID:
8915883
6.

Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus.

Claeys H, Volckaerts A, Mertens W, Liang Z, Fiten P, Opdenakker G.

J Med Virol. 1995 Mar;45(3):273-81.

PMID:
7539833
8.

Genotypes of hepatitis C virus in Nigeria.

Oni AO, Harrison TJ.

J Med Virol. 1996 Jul;49(3):178-86.

PMID:
8818962
9.

Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences.

Yun Z, Lara C, Johansson B, Lorenzana de Rivera I, Sönnerborg A.

J Med Virol. 1996 Jul;49(3):155-60.

PMID:
8818959
10.

[Immunoreactivity studies on synthetic peptides deriving from immunodominant region of hepatitis C virus NS5a gene].

Shi LL, Dou XG, Feng GH, Fields H, Khudyakov Y.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Dec;18(4):344-7. Chinese.

PMID:
15650785
11.

Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.

Nagayama R, Tsuda F, Okamoto H, Wang Y, Mitsui T, Tanaka T, Miyakawa Y, Mayumi M.

J Clin Invest. 1993 Sep;92(3):1529-33.

12.

Significance of specific antibody assay for genotyping of hepatitis C virus.

Tanaka T, Tsukiyama-Kohara K, Yamaguchi K, Yagi S, Tanaka S, Hasegawa A, Ohta Y, Hattori N, Kohara M.

Hepatology. 1994 Jun;19(6):1347-53.

PMID:
7514558
13.

Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations.

Gordon EJ, Bhat R, Liu Q, Wang YF, Tackney C, Prince AM.

J Infect Dis. 2000 Jan;181(1):42-50.

PMID:
10608749
14.

Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections.

Tuveri R, Rothschild C, Pol S, Reijasse D, Persico T, Gazengel C, Bréchot C, Thiers V.

J Med Virol. 1997 Jan;51(1):36-41.

PMID:
8986947
15.

Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections.

Chuang WC, Allain JP.

J Gen Virol. 2008 Aug;89(Pt 8):1890-900. doi: 10.1099/vir.0.83677-0.

PMID:
18632960
16.

Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis.

Tsukiyama-Kohara K, Yamaguchi K, Maki N, Ohta Y, Miki K, Mizokami M, Ohba K, Tanaka S, Hattori N, Nomoto A, et al.

Virology. 1993 Feb;192(2):430-7.

PMID:
7678473
17.

Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.

Attia MA, Zekri AR, Goudsmit J, Boom R, Khaled HM, Mansour MT, de Wolf F, el-Din HM, Sol CJ.

J Clin Microbiol. 1996 Nov;34(11):2665-9.

18.

Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population.

Mison LM, Young IF, O'Donoghue M, Cowley N, Thorlton N, Hyland CA.

Transfusion. 1997 Jan;37(1):73-8.

PMID:
9024493
19.

Supplemental Content

Support Center